Cardiology

MYQORZO™: A Promising New Treatment for Obstructive Hypertrophic Cardiomyopathy

MYQORZO™: A Promising New Treatment for Obstructive Hypertrophic Cardiomyopathy

What is it prescribed for? MYQORZO is used to treat adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM). This is a heart condition where the heart muscle becomes too thick and blocks blood flow out of the heart, making it hard to exercise or even do daily activities. It was approved by the FDA December 2025. MYQORZO is prescribed to help: Improve...

CARDAMYST™: A Promising New Treatment for Sudden Episodes of Rapid Heart Rhythm (PSVT)

CARDAMYST™: A Promising New Treatment for Sudden Episodes of Rapid Heart Rhythm (PSVT)

What is it prescribed for? CARDAMYST is prescribed for adults who have sudden episodes of very fast heart rate called paroxysmal supraventricular tachycardia (PSVT). These episodes often start suddenly and can cause symptoms such as palpitations, dizziness, chest discomfort, or shortness of breath.  It was approved by the FDA December 2025. CARDAMYST is used to...

Introducing Flyrcado: A Breakthrough Diagnostic Tool for Heart Health

Introducing Flyrcado: A Breakthrough Diagnostic Tool for Heart Health

What is the name of the drug and what does it do? Flyrcado (pronounced FLYR-ca-doh), generic name flurpiridaz F 18, is a radioactive diagnostic drug approved on September 27, 2024, used for positron emission tomography (PET) myocardial perfusion imaging (MPI). It is designed to help doctors evaluate blood flow in the heart (myocardial perfusion) and detect areas of...